Glycosylated Peptide Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The global glycosylated peptide market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Peptide drugs are potential therapeutic agents. They are used to treat several diseases due to its features such as high activity, target specificity, low toxicity, and minimal non-specific or drug-drug interactions. Additionally, glycosylation of peptides is a strategy that modulates the physicochemical properties of peptide drugs. Further, it also penetrates peptides across biological membranes as well as enhances bioactivity, selectivity and prolong the half-life of the therapeutic drug. Moreover, there are two types of glycosylation of peptides including N-linked glycosylation or O-linked glycosylation.

The major factor driving the demand for glycosylated peptide is the increasing application of glycosylated peptides coupled with the increasing prevalence of chronic diseases such as cancer, genetic disorders. Moreover, North America is expected to hold a prominent share in the market due to the presence of major players in the region.

To Request a Sample of our Report on Glycosylated Peptide Market: https://www.omrglobal.com/request-sample/glycosylated-peptide-market

Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Bachem Holding AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Pfizer Inc. and OPKO Health Inc. announced the extension of the review period for the Biologics License Application (BLA) by three months to January 2022 for somatrogon, a once-weekly long-acting recombinant human growth hormone, from the US Food and Drug Administration (FDA). Somatrogon is an investigational biologic product that is glycosylated and is used to treat growth hormone deficiency (GHD) in pediatric patients.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Product

• By Distribution Channel

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Bachem Holding AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Glycosylated Peptide Market is Available @ https://www.omrglobal.com/industry-reports/glycosylated-peptide-market

Global Glycosylated Peptide Market Report by Segment

By Product

• Monoclonal Antibodies (mAbs)

• Erythropoietin (EPO)

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Glycosylated Peptide Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.